PressDigest

Valeant closes in on $9.7bn-plus takeover of Salix

Acquisitive Canadian pharmaceuticals company Valeant is on the verge of finalising an agreement to buy US gastrointestinal drug specialist Salix for more than $9.7bn, sources told the Financial Times.

WSJ Logo
Old-School Floor Traders Finally Get Their Day in Court Against CMEExternal link

Old-School Floor Traders Finally Get Their Day in Court Against CME